Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. (Q50763875)

18 March 2018

title

Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. (English)

1 reference

18 March 2018

Gillian M Air

6

0 references

author name string

Upma Gulati

1

1 reference

18 March 2018

Wenxin Wu

2

1 reference

18 March 2018

Shelly Gulati

3

1 reference

18 March 2018

Kshama Kumari

4

1 reference

18 March 2018

Joseph L Waner

5

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 August 2005

1 reference

18 March 2018

number of pages

9

1 reference

inferred from page(s)

published in

Virology

1 reference

18 March 2018

volume

339

1 reference

18 March 2018

issue

1

1 reference

18 March 2018

page(s)

12-20

1 reference

18 March 2018

Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Separation of the complex asparagine-linked oligosaccharides of the glycoprotein fetuin and elucidation of three triantennary structures having sialic acids linked only to galactose residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Differential infection of receptor-modified host cells by receptor-specific influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Two kinds of particles with contrasting properties in influenza A virus strains from the 1957 pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Influenza virus entry and infection require host cell N-linked glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

The release of N-acetyl- and N-glycolloyl-neuraminic acid from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Structures of asparagine-linked oligosaccharides of the glycoprotein fetuin having sialic acid linked to N-acetylglucosamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Human-specific Regulation of α2–6-linked Sialic Acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Microbial recognition of target-cell glycoconjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Resistance of influenza viruses to neuraminidase inhibitors--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Neuraminidase inhibition by chemically sulphated glycopeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Characterization of temperature sensitive influenza virus mutants defective in neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Glycosylation sites identified by solid-phase Edman degradation: O-linked glycosylation motifs on human glycophorin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Chemistry, metabolism, and biological functions of sialic acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Influenza virus infection of desialylated cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Primary structure of human erythrocyte glycophorin A. Isolation and characterization of peptides and complete amino acid sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Binding of influenza viruses to sialic acids: reassortant viruses with A/NWS/33 hemagglutinin bind to alpha2,8-linked sialic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

7 January 2021

inferred from DOI database lookup

Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

7 January 2021

inferred from DOI database lookup

Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.05.009

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VIROL.2005.05.009

1 reference

18 March 2018

1 reference

18 March 2018